|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||15.45 - 15.45|
|52-week range||14.52 - 22.64|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||24.52|
|Forward dividend & yield||0.38 (2.43%)|
|Ex-dividend date||31 Mar 2022|
|1y target est||N/A|
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
In this article we will quickly re-cap the broker forecasts for Smith amp;amp; Nephew (LON:SN.). The Smith amp;amp; Nephew share price has risen by 1.46% ove...
The absence of any nasty surprises, after a couple of disappointing updates in 2021, represents a good start to 2022 for Smith & Nephew and this column continues to believe that the orthopaedics, wound care and sports medicine specialist could yet be a beneficiary of anything like a return to normality in hospitals as and when the pandemic finally wanes.